Erratum to: Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2: C48R: A Novel Mutation in AGPAT2

Documenti analoghi

• Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2: C48R: A Novel Mutation in AGPAT2
  di: Ramanathan, N., et al.
  Pubblicazione: (2012)
• Alterations in Lipid Signaling Underlie Lipodystrophy Secondary to AGPAT2 Mutations
  di: Subauste, Angela R., et al.
  Pubblicazione: (2012)
• Leptin: a novel therapeutic role in lipodystrophy
  di: Savage, D.B., et al.
  Pubblicazione: (2002)
• Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation
  di: Schweisberger, Cintya, et al.
  Pubblicazione: (2021)
• Leu124Serfs*26, a novel AGPAT2 mutation in congenital generalized lipodystrophy with early cardiovascular complications
  di: Montenegro Junior, Renan Magalhães, et al.
  Pubblicazione: (2020)